The UAE is known for its technological advancements and has once again made headlines with its breakthrough in the field of regenerative medicine. The country has achieved independence in EXOSOME production for medical use, which is a huge milestone in the field of regenerative medicine.
According to experts from the leading institute in the field of regenerative medicine, Bioscience Institute, the UAE’s production of EXOSOMES eliminates safety and efficacy issues caused by storage and transportation. This is a game-changer in the field of regenerative medicine as it ensures that patients receive the safest and most effective treatment possible.
Stem cell-derived exosomes have shown potential in various therapeutic applications in regenerative medicine. They are a therapeutic agent for skin rejuvenation and can improve skin elasticity, reduce wrinkles, fine lines, and scars. They can also be used for hair loss, bone, joint cartilage, and intervertebral disc regeneration, as well as tendon and ligament injuries.
In May 2013, the UAE Ministry of Health authorized Bioscience Institute as the Middle East’s first Cell Factory and Clinic for stem cell therapies. This move ensured that all services based on stem cells came under the strict control of the local DHA authority and the Ministry of Health. This has been a boon for UAE residents who can now receive stem cell treatment without any health risks. The strict controls on production have conferred the maximum guarantee of quality and safety of the product.
Producing exosomes locally allows control over the entire production chain starting at the source. This is fundamental as exosomes can derive from many different sources, such as plant sources. However, the effectiveness of the result changes depending on the source. Unfortunately, consumers are still expected to be frauded with exosomes of plant origin available on the market, which are mainly suitable for agriculture, such as enhancing plant growth, stress resistance, inter-kingdom communication, or treating the human digestive system.
Not having to import the exosomes avoids the product’s denaturation and loss of effectiveness due to the lyophilization techniques used for transport and storage. This is a major advantage as no one would use lyophilized products if they could use fresh products.
Exosomes are derived from stem cells that have regenerative properties, making them more potent than PRP, which is derived from platelets that do not have the same properties, effectiveness, and stability. “To better understand exosome modes of action, just look at PRP and imagine a product extremely more powerful and able to mediate the therapeutic efficacy of MSC, such as repair/regeneration, immune modulation, & anti-inflammation, etc.” says Prof. Michele Zocchi, University of Genoa, Italy.
Dubai’s assets in medical tourism are also strengthened as there are very few places in the world where advanced regenerative medicine technology is available, like the one in Dubai. This will boost the country’s medical tourism industry as patients from around the world will flock to the UAE for advanced regenerative medicine treatments.
In conclusion, the UAE’s achievement in the production of EXOSOMES for medical use is a major breakthrough in the field of regenerative medicine. It eliminates the need for storage and transportation, ensuring that patients receive the safest and most effective treatment possible. This move will revolutionize the field of regenerative medicine, and the UAE is at the forefront of this revolution.
Visit the Website for more details.